NEDxA, with its slogan ‘Plug / Play / Genotype’, is a microfluidic ‘Lab-on-a-Chip’ which is designed to perform in vitro diagnostics virtually anywhere. The Point Of Care device is portable, easy to use, and does not need to be operated by specialized personnel. Not only that, but it also drastically reduces analysis time, and includes an integrated touch screen for easy access to results.
The NEDxA array presented this week focuses on the detection and genotyping of high-risk HPV subtypes, but this is just the first disease in a extensive menu of detection panels planned for the instrument.
IBEC’s joint unit with GENOMICA, the leading Spanish company in molecular diagnostics, was set up in 2015 to enable researchers and industry technicians to share a host of know-how and in-house capabilities to develop and bring to market point-of-care diagnostic products and other medical devices and technologies. The unit is located at IBEC’s headquarters in Barcelona.
The MEDICA meeting (below), organised by the Messe Düsseldorf Group, has been held in Düsseldorf for more than 45 years. This leading show in the industry has more than 4,900 exhibitors and 130,000 visitors.